This Funding Opportunity Announcement (FOA) seeks grant applications from small business concerns (SBCs) to develop Artificial Intelligence (AI)-related technologies for drug discovery and drug development for Substance Use Disorders (SUD), excluding alcohol use disorder.
Companion FOA: RFA-DA-22-021 STTR R41/R42 - Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed)
Application Due Date(s): August 10, 2021
RFA-DA-22-019 Expiration Date August 11, 2021
Eligibility Requirements
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.